News
Depemokimab significantly reduces asthma exacerbations, benefiting patients regardless of their baseline asthma control levels. A biologics license application for depemokimab is currently being ...
The GINA 2025 asthma update includes new guidance on T2 biomarkers, asthma in young children, and climate change, as well as ...
Women working permanent night shifts vs. day shifts faced an elevated likelihood for moderate to severe asthma, whereas this was not observed in men, according to results published in ERJ Open ...
New specialized treatment center offers comprehensive care for those struggling with persistent breathing difficulties.
Discover how urban environments create distinct asthma phenotypes and which city triggers are causing the most breathing ...
U.S. Senator Maggie Hassan said on Friday she is launching an investigation into British pharmaceutical giant GlaxoSmithKline ...
Etokimab (I-Mab Biopharma), which is optimized for common IL-33 gene polymorphisms, has completed patient recruitment in its ...
Biological drugs have been a game-changer for people with severe asthma, helping them breathe easier and live more ...
This updated asthma guideline establishes a consistent approach to improving asthma diagnosis and control in adults and ...
China: A recent systematic review and meta-analysis published in Frontiers in Medicine highlights the potential role of the ...
Long-term workplace exposures to chemical irritants and sensitizers increase the risk and incidence of adult-onset asthma.
Adult asthma affects more than 25 million Americans, yet many sufferers unknowingly engage in daily practices that exacerbate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results